| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.703 | 16.069 | 17.611 | 15.097 | 16.371 |
| Total Income - EUR | - | - | - | - | - | 9.708 | 16.144 | 17.636 | 15.127 | 16.373 |
| Total Expenses - EUR | - | - | - | - | - | 88 | 122 | 174 | 7.931 | 7.842 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 9.620 | 16.022 | 17.462 | 7.196 | 8.531 |
| Net Profit/Loss - EUR | - | - | - | - | - | 9.343 | 15.539 | 16.960 | 7.052 | 8.375 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Zian Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 9.682 | 15.743 | 17.082 | 7.939 | 8.641 |
| Inventories | - | - | - | - | - | 133 | 130 | 131 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.291 | 2.288 | 1.134 | 2.251 | 515 |
| Cash | - | - | - | - | - | 8.257 | 13.324 | 15.817 | 5.687 | 8.126 |
| Shareholders Funds | - | - | - | - | - | 9.236 | 15.587 | 17.008 | 7.101 | 8.424 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 446 | 156 | 73 | 838 | 218 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7120 - 7120" | |||||||||
| CAEN Financial Year |
7120
|
|||||||||
Comments - Zian Pharma S.r.l.